Your browser doesn't support javascript.
loading
Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva.
Faustini, Sian E; Jossi, Sian E; Perez-Toledo, Marisol; Shields, Adrian M; Allen, Joel D; Watanabe, Yasunori; Newby, Maddy L; Cook, Alex; Willcox, Carrie R; Salim, Mahboob; Goodall, Margaret; Heaney, Jennifer L; Marcial-Juarez, Edith; Morley, Gabriella L; Torlinska, Barbara; Wraith, David C; Veenith, Tonny V; Harding, Stephen; Jolles, Stephen; Ponsford, Mark J; Plant, Tim; Huissoon, Aarnoud; O'Shea, Matthew K; Willcox, Benjamin E; Drayson, Mark T; Crispin, Max; Cunningham, Adam F; Richter, Alex G.
  • Faustini SE; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Jossi SE; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Perez-Toledo M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Shields AM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Allen JD; School of Biological Sciences, University of Southampton, Southampton, UK.
  • Watanabe Y; School of Biological Sciences, University of Southampton, Southampton, UK.
  • Newby ML; Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford, UK.
  • Cook A; School of Biological Sciences, University of Southampton, Southampton, UK.
  • Willcox CR; Binding Site Group Ltd, Birmingham, UK.
  • Salim M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Goodall M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Heaney JL; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Marcial-Juarez E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Morley GL; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Torlinska B; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
  • Wraith DC; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Veenith TV; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Harding S; Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, Birmingham, UK.
  • Jolles S; Binding Site Group Ltd, Birmingham, UK.
  • Ponsford MJ; Immunodeficiency Centre for Wales, Cardiff, UK.
  • Plant T; Immunodeficiency Centre for Wales, Cardiff, UK.
  • Huissoon A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • O'Shea MK; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Willcox BE; Department of Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Drayson MT; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
  • Crispin M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Cunningham AF; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Richter AG; School of Biological Sciences, University of Southampton, Southampton, UK.
Immunology ; 164(1): 135-147, 2021 09.
Article en En | MEDLINE | ID: mdl-33932228

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoglobulina A / Inmunoglobulina G / Inmunoglobulina M / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoglobulina A / Inmunoglobulina G / Inmunoglobulina M / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article